Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit

Clinical observations stemming from widespread employment of restorative L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for management of dyskinesia in Parkinson’s Disease (PD) patients implicate a regulatory role for endogenous morphine in central nervous system dopamine neurotransmission. Reciproca...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano, George B., Mantione, Kirk J., Králíčková, Milena, Ptacek, Radek, Kuzelova, Hana, Esch, Tobias, Kream, Richard M.
Format: Artigo
Language:Inglês
Published: International Scientific Literature, Inc. 2012
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3560700/
https://ncbi.nlm.nih.gov/pubmed/22847214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.883259
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items